Temsamani Karim Saad bought CDLX

March 22, 2024 · Form 4 insider transaction

Temsamani Karim Saad bought 300,000 shares of Cardlytics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
300,000
Price
$0.00
Total value
N/A
Role
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateMarch 22, 2024
Filing dateMarch 25, 2024
Shares owned after300,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.; 50% of the RSUs shall vest on April 1, 2025, and the remaining 50% shall vest quarterly in equal amounts over the subsequent twelve-month period, provided that the Reporting Person remains employed by the Issuer on such vesting date.

View the original Form 4 on SEC EDGAR